Beyond Cutibacterium acnes: The Biofilm Paradigm in Treatment-Resistant Skin Pathology

For years, the clinical approach to acne has been 'seek and destroy.' The target was Cutibacterium acnes (formerly Propionibacterium acnes), and the weapons were topical benzoyl peroxide and systemic antibiotics. However, this strategy is failing, as evidenced by the rising rates of antibiotic resistance and the chronic nature of the condition for millions. The flaw lies in the premise: C. acnes is not a pathogen; it is a vital commensal that secretes propionic acid to keep the skin's pH low and produces antioxidants that protect skin lipids. The real issue is not the presence of the bacteria, but its transition from a planktonic (free-floating) state into a biofilm. A biofilm is a complex community of bacteria encased in a protective polysaccharide matrix, which makes them up to 1,000 times more resistant to antibiotics and the host's immune system.

Within the follicles, these biofilms act as a persistent source of inflammation and sebum obstruction. Furthermore, recent genomic sequencing has revealed that not all C. acnes are created equal. There are specific 'phylotypes' associated with health (e.g., RT6) and others associated with acne (e.g., RT4). In a healthy individual, these phylotypes exist in a balance that prevents any one group from forming a pathogenic biofilm. Conventional medicine, by using broad-spectrum antibiotics, kills both the beneficial and the pathogenic strains, often allowing the more resilient, biofilm-forming strains to dominate upon repopulation.

This is why acne often returns with greater severity after a course of tetracyclines. Environmental factors such as high-glycaemic diets and hormonal fluctuations increase sebum production, providing the fuel (lipids) that these biofilms need to expand. To address treatment-resistant acne, the focus must shift from total eradication to biofilm disruption and phylotype rebalancing. This involves the use of substances like salicylic acid, which can penetrate the biofilm matrix, and the application of topical probiotics or prebiotics that specifically encourage the growth of health-associated strains. By understanding the biofilm paradigm, we move away from the 'sterilisation' mindset and toward an 'ecological' mindset that treats the skin as a living, breathing garden.